These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 17133608)

  • 41. Association of interleukin 23 receptor polymorphisms with anti-topoisomerase-I positivity and pulmonary hypertension in systemic sclerosis.
    Agarwal SK; Gourh P; Shete S; Paz G; Divecha D; Reveille JD; Assassi S; Tan FK; Mayes MD; Arnett FC
    J Rheumatol; 2009 Dec; 36(12):2715-23. PubMed ID: 19918037
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Autoreactive T cells to topoisomerase I in monozygotic twins discordant for systemic sclerosis.
    Kuwana M; Feghali CA; Medsger TA; Wright TM
    Arthritis Rheum; 2001 Jul; 44(7):1654-9. PubMed ID: 11465716
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An immunodominant epitope on DNA topoisomerase I is conformational in nature: heterogeneity in its recognition by systemic sclerosis sera.
    Kuwana M; Kaburaki J; Medsger TA; Wright TM
    Arthritis Rheum; 1999 Jun; 42(6):1179-88. PubMed ID: 10366110
    [TBL] [Abstract][Full Text] [Related]  

  • 44. R620W polymorphism of protein tyrosine phosphatase PTPN22 in Egyptian children and adolescents with systemic lupus erythematosus: relation to thyroid autoimmunity.
    Hamza RT; Awwad KS; Temsah KA; Hamed AI
    Int J Adolesc Med Health; 2013; 25(2):143-9. PubMed ID: 23314521
    [TBL] [Abstract][Full Text] [Related]  

  • 45. STAT4 is a genetic risk factor for systemic sclerosis in a Chinese population.
    Yi L; Wang JC; Guo XJ; Gu YH; Tu WZ; Guo G; Yang L; Xiao R; Yu L; Mayes MD; Assassi S; Jin L; Zou HJ; Zhou XD
    Int J Immunopathol Pharmacol; 2013; 26(2):473-478. PubMed ID: 23755762
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The R620W polymorphism of the protein tyrosine phosphatase 22 gene in autoimmune thyroid diseases and rheumatoid arthritis in the Tunisian population.
    Chabchoub G; Teixiera EP; Maalej A; Ben Hamad M; Bahloul Z; Cornelis F; Ayadi H
    Ann Hum Biol; 2009; 36(3):342-9. PubMed ID: 19343596
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The functional PTPN22 C1858T polymorphism confers risk for rheumatoid arthritis in patients from Central Mexico.
    Rincón JF; Cano DL; Morales SJ; Jiménez ML; Cobos RE; Bello JR
    Clin Rheumatol; 2016 Jun; 35(6):1457-62. PubMed ID: 26951256
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evidence of the contribution of the X chromosome to systemic sclerosis susceptibility: association with the functional IRAK1 196Phe/532Ser haplotype.
    Dieudé P; Bouaziz M; Guedj M; Riemekasten G; Airò P; Müller M; Cusi D; Matucci-Cerinic M; Melchers I; Koenig W; Salvi E; Wichmann HE; Cuomo G; Hachulla E; Diot E; Hunzelmann N; Caramaschi P; Mouthon L; Riccieri V; Distler J; Tarner I; Avouac J; Meyer O; Kahan A; Chiocchia G; Boileau C; Allanore Y
    Arthritis Rheum; 2011 Dec; 63(12):3979-87. PubMed ID: 21898345
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The PTPN22 620W allele is a risk factor for Wegener's granulomatosis.
    Jagiello P; Aries P; Arning L; Wagenleiter SE; Csernok E; Hellmich B; Gross WL; Epplen JT
    Arthritis Rheum; 2005 Dec; 52(12):4039-43. PubMed ID: 16320352
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-topoisomerase I antibodies in silica-associated systemic sclerosis. A model for autoimmunity.
    McHugh NJ; Whyte J; Harvey G; Haustein UF
    Arthritis Rheum; 1994 Aug; 37(8):1198-205. PubMed ID: 8053959
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Longitudinal analysis of autoantibody response to topoisomerase I in systemic sclerosis.
    Kuwana M; Kaburaki J; Mimori T; Kawakami Y; Tojo T
    Arthritis Rheum; 2000 May; 43(5):1074-84. PubMed ID: 10817562
    [TBL] [Abstract][Full Text] [Related]  

  • 52. IgG reactivity with a 100-kDa tissue and endothelial cell antigen identified as topoisomerase 1 distinguishes between limited and diffuse systemic sclerosis patients.
    García de la Peña-Lefebvre P; Chanseaud Y; Tamby MC; Reinbolt J; Batteux F; Allanore Y; Kahan A; Meyer O; Benveniste O; Boyer O; Guillevin L; Boissier MC; Mouthon L
    Clin Immunol; 2004 Jun; 111(3):241-51. PubMed ID: 15183145
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Polymorphism of immunoglobulin enhancer element HS1,2A: allele *2 associates with systemic sclerosis. Comparison with HLA-DR and DQ allele frequency.
    Frezza D; Giambra V; Tolusso B; De Santis M; Bosello S; Vettori S; Triolo G; Valentini G; Ferraccioli G
    Ann Rheum Dis; 2007 Sep; 66(9):1210-5. PubMed ID: 17392350
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-CENP-B response in sera of uranium miners exposed to quartz dust and patients with possible development of systemic sclerosis (scleroderma).
    Conrad K; Stahnke G; Liedvogel B; Mehlhorn J; Barth J; Blasum C; Altmeyer P; Sönnichsen N; Frank KH
    J Rheumatol; 1995 Jul; 22(7):1286-94. PubMed ID: 7562760
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Coexistence of antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis.
    Dick T; Mierau R; Bartz-Bazzanella P; Alavi M; Stoyanova-Scholz M; Kindler J; Genth E
    Ann Rheum Dis; 2002 Feb; 61(2):121-7. PubMed ID: 11796397
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The FAS -670A>G polymorphism influences susceptibility to systemic sclerosis phenotypes.
    Broen J; Gourh P; Rueda B; Coenen M; Mayes M; Martin J; Arnett FC; Radstake TR;
    Arthritis Rheum; 2009 Dec; 60(12):3815-20. PubMed ID: 19950259
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunization with DNA topoisomerase I induces autoimmune responses but not scleroderma-like pathologies in mice.
    Hu PQ; Hurwitz AA; Oppenheim JJ
    J Rheumatol; 2007 Nov; 34(11):2243-52. PubMed ID: 17937466
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of PTPN22 gene functional variants with development of pulmonary tuberculosis in Moroccan population.
    Lamsyah H; Rueda B; Baassi L; Elaouad R; Bottini N; Sadki K; Martin J
    Tissue Antigens; 2009 Sep; 74(3):228-32. PubMed ID: 19563523
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Severe systemic sclerosis with anti-topoisomerase I antibodies is associated with an HLA-DRw11 allele.
    Morel PA; Chang HJ; Wilson JW; Conte C; Saidman SL; Bray JD; Tweardy DJ; Medsger TA
    Hum Immunol; 1994 Jun; 40(2):101-10. PubMed ID: 7928439
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical significance of coexisting antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis: a EUSTAR group-based study.
    Heijnen IA; Foocharoen C; Bannert B; Carreira PE; Caporali R; Smith V; Kumánovics G; Becker MO; Vanthuyne M; Simsek I; Bocelli-Tyndall C; Walker UA
    Clin Exp Rheumatol; 2013; 31(2 Suppl 76):96-102. PubMed ID: 23101460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.